Shire Share News (SHP)

16 Sep 2016

By Hillary Flynn NEW YORK, Sept 16 (IFR) - Drugmaker Shire (Baa3/BBB-) is readying an up to US$12bn M&A bond, the next test for the corporate bond mar...

16 Sep 2016

By Natalie Harrison and Davide Scigliuzzo NEW YORK, Sept 16 (IFR) - There are still no visible signs of fatigue in the US high-grade corporate bond ma...

15 Sep 2016

(adds background) By Hillary Flynn NEW YORK, Sept 15 (IFR) - Biopharm company Gilead Sciences led another busy session in the US primary bond market o...

14 Sep 2016

(ShareCast News) - The US Food and Drug Administration has granted approval for Shire's Cuvitru drug for the treatment of patients with primary immuno...

8 Sep 2016

(Adds quotes, detail) By John Balassi and Mike Gambale NEW YORK, Sept 8 (IFR) - The US investment-grade bond market has logged its second busiest week...

7 Sep 2016

(Adds loan details) By Hillary Flynn NEW YORK, Sept 7 (IFR) - Drugmaker Shire Plc will start marketing a benchmark US dollar bond early next week, acc...

7 Sep 2016

By Hillary Flynn NEW YORK, Sept 7 (IFR) - Drugmaker Shire Plc will start marketing a benchmark US dollar bond early next week, according to a note sen...

5 Sep 2016

LONDON, Sept 5 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the late...